The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Graves’ Disease
Open accessAbstract
Graves' disease is an autoimmune disorder in which the thyroid is activated by antibodies to the thyrotropin receptor. The hyperthyroidism that develops is one of many somatic and psychiatric manifestations of the disease that can affect the quality and length of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Groot, L., Abalovich, M., Alexander, E. K., Amino, N., Barbour, L., Cobin, R. H., Eastman, C. J., Lazarus, J. H., Luton, D., Mandel, S. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2803 · Cited by 1,866
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Iodine deficiency and thyroid disorders
Zimmermann, M. B., & Boelaert, K. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70225-6 · Cited by 930
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY
Hanafusa, T., Chiovato, L., Doniach, D., Pujol-Borrell, R., Russell, R. C. G., & Bottazzo, G. F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90628-1 · Cited by 706
Selenium and the Course of Mild Graves' Orbitopathy
Marcocci, C., Kahaly, G. J., Krassas, G. E., Bartalena, L., Prummel, M., Stahl, M., Altea, M. A., Nardi, M., Pitz, S., Boboridis, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012985 · Cited by 619
Clinical Features of Graves' Ophthalmopathy in an Incidence Cohort
BARTLEY, G. B., FATOURECHI, V., KADRMAS, E. F., JACOBSEN, S. J., ILSTRUP, D. M., GARRITY, J. A., & GORMAN, C. A. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70276-4 · Cited by 459
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A., Hale, G., Chatterjee, V. K., Waldmann, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02429-0 · Cited by 453
Salvi, M., Vannucchi, G., Currò, N., Campi, I., Covelli, D., Dazzi, D., Simonetta, S., Guastella, C., Pignataro, L., Avignone, S., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3014 · Cited by 412
Bartalena, L., Baldeschi, L., Dickinson, A. J., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M. P., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0315 · Cited by 406
Wiersinga, W. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12222 · Cited by 389
Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity
Zang, S., Ponto, K. A., & Kahaly, G. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1962 · Cited by 379
Cancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
Tsui, S., Naik, V., Hoa, N., Hwang, C. J., Afifiyan, N. F., Sinha Hikim, A., Gianoukakis, A. G., Douglas, R. S., & Smith, T. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4397 · Cited by 372
Self-citationBartalena, L., Krassas, G. E., Wiersinga, W., Marcocci, C., Salvi, M., Daumerie, C., Bournaud, C., Stahl, M., Sassi, L., Veronesi, G., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2389 · Cited by 370
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
Stan, M. N., Garrity, J. A., Carranza Leon, B. G., Prabin, T., Bradley, E. A., & Bahn, R. S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2572 · Cited by 369
MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new players
Effraimidis, G., & Wiersinga, W. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0047 · Cited by 350
A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Burch, H. B., Burman, K. D., & Cooper, D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2802 · Cited by 345
Bonnema, S. J., & Hegedüs, L. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 339
Self-citationBartalena, L., & Tanda, M. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0806317 · Cited by 336
Management of Graves Disease: A Review
Burch, H. B., & Cooper, D. S. (2015) · JAMA · doi:10.1001/jama.2015.16535 · Cited by 332
Cooper, D. S., & Laurberg, P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70086-x · Cited by 310
Marcocci, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3562 · Cited by 309
Diagnosis and management of Graves disease: a global overview
Bartalena, L. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.193 · Cited by 296
Pritchard, J., Han, R., Horst, N., Cruikshank, W. W., & Smith, T. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6348 · Cited by 295
Self-citationExpression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue
Feliciello, A., Ciullo, I., Fenzi, G. F., Bonavolontà, G., Porcellini, A., & Avvedimento, E. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91475-2 · Cited by 288
Mechanisms of Autoimmune Thyroid Diseases: From Genetics to Epigenetics
Tomer, Y. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104713 · Cited by 274
Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin
Tellez, M., Cooper, J., & Edmonds, C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01445.x · Cited by 202
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
A 2013 European survey of clinical practice patterns in the management of Graves' disease
Bartalena, L., Burch, H. B., Burman, K. D., & Kahaly, G. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12688 · Cited by 197
Boelaert, K., Torlinska, B., Holder, R. L., & Franklyn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2495 · Cited by 196
Tozzoli, R., Bagnasco, M., Giavarina, D., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.003 · Cited by 195
Cao, H. J., Wang, H.-S., Zhang, Y., Lin, H.-Y., Phipps, R. P., & Smith, T. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29615 · Cited by 195
Self-citationBrix, T. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.930 · Cited by 188
Psychosocial morbidity of Graves’ orbitopathy
Kahaly, G. J., Petrak, F., Hardt, J., Pitz, S., & Egle, U. T. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02352.x · Cited by 184
Analysis of 754 Cases of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan
Nakamura, H., Miyauchi, A., Miyawaki, N., & Imagawa, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2569 · Cited by 180
Graves' disease. Influence of age on clinical findings
Nordyke, R. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.3.626 · Cited by 174
Characterization of Thyrotropin Receptor Antibody-Induced Signaling Cascades
Morshed, S. A., Latif, R., & Davies, T. F. (2009) · Endocrinology · doi:10.1210/en.2008-0878 · Cited by 164
Erbil, Y., Ozluk, Y., Giriş, M., Salmaslıoglu, A., Issever, H., Barbaros, U., Kapran, Y., Özarmağan, S., & Tezelman, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0229 · Cited by 157
Douglas, R. S., Gianoukakis, A. G., Kamat, S., & Smith, T. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3281 · Cited by 157
Self-citationDouglas, R. S., Naik, V., Hwang, C. J., Afifiyan, N. F., Gianoukakis, A. G., Sand, D., Kamat, S., & Smith, T. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5768 · Cited by 148
Self-citationMorbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142
Self-citationThyroid-stimulating antibody activity between different immunoglobulin G subclasses.
Weetman, A. P., Yateman, M., Ealey, P. A., Black, C. M., Reimer, C. B., Williams, R. C., Shine, B. S. F., & Marshall, N. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114768 · Cited by 136
Thyroid dermopathy and acropachy
Fatourechi, V. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.10.001 · Cited by 134
Fukata, S., Kuma, K., & Sugawara, M. (1999) · Thyroid · doi:10.1089/thy.1999.9.29 · Cited by 126
Limbach, M., Saare, M., Tserel, L., Kisand, K. E., Eglit, T., Sauer, S., Axelsson, T., Syvänen, A., Metspalu, A., Milani, L. A., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.09.006 · Cited by 120
Efficacy and Safety of Orbital Radiotherapy for Graves' Orbitopathy
Tanda, M. L., & Bartalena, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2758 · Cited by 114
Armengol, M., Cardoso-Schmidt, C. B., Fernández, M. A., Ferrer, X., Pujol‐Borrell, R., & Juan, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6320 · Cited by 112
Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0708 · Cited by 111
Self-citationThyroid Function and Intellectual Development of Infants Nursed by Mothers Taking Methimazole
Azizi, F., Khoshniat, M., Bahrainian, M., & Hedayati, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6810 · Cited by 110
Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., & Laurberg, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01347.x · Cited by 108
Antithyroid Drug Side Effects in the Population and in Pregnancy
Andersen, S. L., Olsen, J., & Laurberg, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4274 · Cited by 107
Ljunggren, J., Törring, O., Wallin, G., Taube, A., Tallstedt, L., Hamberger, B., & Lundell, G. E. F. (1998) · Thyroid · doi:10.1089/thy.1998.8.653 · Cited by 101
Thyroid function in wholly breast‐feeding infants whose mothers take high doses of propylthiouracil
Momotani, N., Yamashita, R., Makino, F., Noh, J. Y., Ishikawa, N., Ito, K., & Ito, K. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01078.x · Cited by 94
Human fibrocytes coexpress thyroglobulin and thyrotropin receptor
Fernando, R., Atkins, S., Raychaudhuri, N., Lu, Y., Li, B., Douglas, R. S., & Smith, T. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202064109 · Cited by 90
Self-citationBrandt, F., Almind, D., Christensen, K., Green, A., Brix, T. H., & Hegedüs, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2268 · Cited by 83
Self-citationMitchell, A. L., Gan, E. H., Morris, M., Johnson, K., Neoh, C., Dickinson, A. J., Perros, P., & Pearce, S. H. S. (2013) · Clinical Endocrinology · doi:10.1111/cen.12141 · Cited by 79
Feroci, F., Rettori, M., Borrelli, A., Coppola, A., Castagnoli, A., Perigli, G., Cianchi, F., & Scatizzi, M. (2013) · Surgery · doi:10.1016/j.surg.2013.10.017 · Cited by 76
Standardization of a Bioassay for Thyrotropin Receptor Stimulating Autoantibodies
Diana, T., Kanitz, M., Lehmann, M., Li, Y., Olivo, P. D., & Kahaly, G. J. (2014) · Thyroid · doi:10.1089/thy.2014.0346 · Cited by 74
Smith, T. J., Sciaky, D., Phipps, R. P., & Jennings, T. A. (1999) · Thyroid · doi:10.1089/thy.1999.9.749 · Cited by 70
Self-citationBoboridis, K. G., Uddin, J. M., Mikropoulos, D. G., Bunce, C., Mangouritsas, G., Voudouragkaki, I. C., & Konstas, A. G. P. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0228-y · Cited by 65
Fernando, R., Lu, Y., Atkins, S. J., Mester, T., Branham, K. E. H., & Smith, T. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4271 · Cited by 64
Self-citationLow- Versus High-Dose Radiotherapy for Graves' Ophthalmopathy: A Randomized, Single Blind Trial
Kahaly, G. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.102 · Cited by 60
Sisti, E., Coco, B., Menconi, F., Leo, M., Rocchi, R., Latrofa, F., Profilo, M. A., Mazzi, B., Albano, E., Vitti, P., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0712 · Cited by 58
Coexpression of CD40 and Class II Antigen HLA-DR in Graves’ Disease Thyroid Epithelial Cells
Faure, G. C., Bensoussan, D., Béné, M. C., Aubert, V. D., & Leclère, J. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4391 · Cited by 54
Treating the thyroid in the presence of Graves’ ophthalmopathy
Hegedűs, L. D., Bonnema, S. J., Smith, T. J., & Brix, T. H. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.005 · Cited by 38
Self-citationDouglas, R. S. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.232 · Cited by 35
Nagata, K., Nakayama, Y., Higaki, K., Ochi, M., Kanai, K., Matsushita, M., Kuwamoto, S., Kato, M., Murakami, I., Iwasaki, T., et al. (2015) · Autoimmunity · doi:10.3109/08916934.2015.1022163 · Cited by 30
Novel Thermal Imaging Analysis Technique for Detecting Inflammation in Thyroid Eye Disease
Maria, C. D., Allen, J., Dickinson, J., Neoh, C., & Perros, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1957 · Cited by 28
Brandt, F., Thvilum, M., Hegedűs, L. D., & Brix, T. H. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0306 · Cited by 28
Self-citationJellema, H. M., Braaksma‐Besselink, Y., Limpens, J., et al. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12717 · Cited by 26
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 940
Self-citationTeprotumumab for Thyroid-Associated Ophthalmopathy
Smith, T. J., Kahaly, G. J., Ezra, D. G., Fleming, J. C., Dailey, R. A., Tang, R. A., Harris, G. J., Antonelli, A., Salvi, M., Goldberg, R. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614949 · Cited by 756
Self-citationTeprotumumab for the Treatment of Active Thyroid Eye Disease
Douglas, R. S., Kahaly, G. J., Patel, A., Sile, S., Thompson, E. H. Z., Perdok, R., Fleming, J. C., Fowler, B. T., Marcocci, C., Marinò, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910434 · Cited by 752
Self-citationConnelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Metadata
- Authors
- Smith, T. J., & Hegedüs, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-10-20
- Volume
- 375
- Issue
- 16
- Pages
- 1552-1565
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4246035014
- Cited by
- 1,257
- References
- 72
- FWCI
- 67.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.